Login
$CBNA
$51.36 +$0.35 (0.69%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Assets
Cash and due from banks
Interest-bearing deposits in other banks
Total cash and cash equivalents
Securities available for sale, at fair value
Securities held to maturity, at carrying value, net of allowance for credit losses of $91 and $128, respectively (fair value of $212,427 and $245,276, respectively)
Equity securities, at fair value
Restricted securities, at cost
Loans held for sale
Loans, net of allowance for credit losses of $3,714 and $4,096, respectively
Premises and equipment, net of accumulated depreciation of $8,055 and $7,755, respectively
Accrued interest receivable
Other assets
Total assets
Liabilities and stockholders’ equity
Liabilities
Deposits:
Noninterest-bearing
Savings, interest-bearing checking and money market accounts
Time, $250 and over
Other time
Total deposits
Short-term borrowings
Accrued interest payable
Accrued expenses and other liabilities
Total liabilities
Stockholders’ equity
Preferred stock: No par value, 100,000 shares authorized, no shares issued and outstanding
Class A and B Common Stock
Class A Common Stock
Class B Common Stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support